Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
and molecular biology assays, DNA damage assays (e.g. comet assay) expertise in handling and characterizing particles (e.g. DLS) excellent writing and communication skills (English) as well as ability
-
tumors with a high level of subclonal genetic heterogeneity to understand the general rules of how gene dosage affects expression, as well as longitudinally during treatment to better understand genetic
-
to leukemias and solid tumors with a high level of subclonal genetic heterogeneity to understand the general rules of how gene dosage affects expression, as well as longitudinally during treatment to better
-
maintaining collaborations. The applicant shall also be responsible for interactions with other collaborators important to the project area. Eligibility requirements The successful candidate should have: A PhD
-
of the group is to combine these different areas of research to get insights into disease pathophysiology and to develop novel treatments. The successful candidate will join an international team of enthusiastic
-
for doctoral/third-cycle/PhD education if you: have been awarded a second-cycle/advanced/master qualification (i.e. master degree), or have satisfied the requirements for courses comprising at least 240 credits
-
/Pathology . We are looking for you who wants to join our team and work primarily with handling our blood samples from lung cancer patients with a focus on extracellular vesicles. Your mission You will be one
-
experience in cell and molecular biology. Expertise and experience in rodent animal handling and surgery, with a focus on skeletal muscle. Experience of using stable isotopes and Inductively Coupled Plasma
-
liquid handling robotic platforms and analysed by single-cell mRNA-seq., Mass/Flow cytometry and plasma protein assays. The Brodin lab is looking to hire a postdoc to study immune microbe interactions
-
Do you want to contribute to top quality medical research? You will be a part of the Kallioniemi research group . Our group focuses on optimizing treatments for individual cancer patients based